English: Alcohol misuse is also a major health issue affecting individuals, families and communities, and preventing the harm caused by alcohol continues to be a priority for the Government. We are committed to ensuring that our services provide early intervention and prevention, so that longer term harms are prevented before they occur. In 2022 to 2023, we increased our investment in the substance misuse agenda to almost £64 million, of which over £36 million was allocated to area planning boards, who commission alcohol services. A further £3 million has been earmarked for area planning boards in 2023-24 as part of the draft budget. We believe the introduction of a minimum unit price for alcohol will help reduce alcohol-related harm and support people to drink responsibly. Evidence shows that introducing an MUP for alcohol will make an important contribution in tackling the health risks associated with excessive alcohol consumption and alcohol-specific deaths in Wales by reducing alcohol consumption in hazardous and harmful drinkers. Welsh Government also remains committed to the World Health Organization elimination agenda for hepatitis B and C, which includes targets to reduce viral hepatitis incidence by 90 per cent, and to reduce mortality due to hepatitis B and C by 65 per cent by 2030. A new hepatitis B and C elimination programme oversight group has been established to drive the elimination agenda here in Wales. The group includes representation from Welsh Government, Public Health Wales, hepatitis B and C health services and the third sector. The first action of this group was to agree on the content of a communication that will set out a road map in order to reinvigorate the drive to eliminate hepatitis B and C as a public health threat by 2030. This is due to be published imminently. In terms of our wider approach to liver disease, Welsh Government, health boards and the emerging NHS executive network structures are working closely together to drive forward implementation of the liver disease quality statement. The quality statement sets out our vision for high-quality liver disease services over the next decade. It aims to deliver better outcomes on the prevention, diagnosis and treatment of liver disease here in Wales. This includes supporting a range of initiatives, some of which were put forward in point 4 of today's motion: initiatives such as continuing to highlight the significant benefits of introducing emergency department alcohol screening and seven-day alcohol care teams in secondary care to meet local need; expanding the use of the all-Wales liver blood test pathway in primary care, underpinned by the Institute of Clinical Science and Technology; funding of staff to reduce waits for non-invasive detection of chronic liver disease; funding of Love Your Liver campaigns by the British Liver Trust; improving provision for gastroenterology trainees in Wales to undertake advanced hepatology training leading to an improved pipeline of consultant hepatologists. The liver disease implementation group are currently developing a work programme to support the implementation of the quality statement, and timescales and priorities will be considered as part of this process. In terms of the call for a doubling of hepatology staff in Wales, health boards and NHS trusts are responsible for recruitment and workforce planning, supported by Health Education and Improvement Wales and other partner organisations. We need to develop an approach to the hepatology workforce that achieves the right match between demand and supply, and we are determined to address the underlying issues of staff recruitment, retention and effective workforce planning, to ensure that we can provide the right number of healthcare staff to meet the care needs of our patients. The workforce strategy, published by HEIW and Social Care Wales, sets out our long-term vision and actions for the health and social care workforce. We have also developed a shorter term workforce plan to help with the current pressures on our workforce, which the Minister for Health and Social Services expects to publish in the coming weeks. In conclusion, I would like to reassure the Chamber that reducing deaths from liver disease through prevention and early diagnosis remains a priority for the Government, and I ask the Chamber to support the Government's amendment today. Diolch.
Welsh: Mae camddefnyddio alcohol hefyd yn broblem iechyd fawr sy'n effeithio ar unigolion, teuluoedd a chymunedau, ac mae atal y niwed a achosir gan alcohol yn parhau i fod yn flaenoriaeth i'r Llywodraeth. Rydym wedi ymrwymo i sicrhau bod ein gwasanaethau yn atal ac ymyrryd yn gynnar, fel bod niwed mwy hirdymor yn cael ei atal cyn iddo ddigwydd. Yn 2022 i 2023, fe wnaethom gynyddu ein buddsoddiad yn yr agenda camddefnyddio sylweddau i bron i £64 miliwn, a dyrannwyd dros £36 miliwn ohono i fyrddau cynllunio ardal, sy'n comisiynu gwasanaethau alcohol. Mae £3 miliwn arall wedi'i glustnodi ar gyfer byrddau cynllunio ardal yn 2023-24 fel rhan o'r gyllideb ddrafft. Credwn y bydd cyflwyno isafbris uned ar gyfer alcohol yn helpu i leihau niwed sy'n gysylltiedig ag alcohol ac yn cynorthwyo pobl i yfed yn gyfrifol. Mae tystiolaeth yn dangos y bydd cyflwyno isafbris uned ar gyfer alcohol yn gwneud cyfraniad pwysig tuag at fynd i'r afael â'r risgiau iechyd sy'n gysylltiedig ag yfed gormod o alcohol a marwolaethau sy'n ymwneud yn benodol ag alcohol yng Nghymru drwy leihau faint o alcohol a gaiff ei yfed gan rai sy'n yfed i raddau peryglus a niweidiol. Mae Llywodraeth Cymru hefyd yn parhau i fod yn ymrwymedig i agenda ddileu hepatitis B ac C Sefydliad Iechyd y Byd, sy'n cynnwys targedau i leihau nifer yr achosion o hepatitis feirysol 90 y cant, a lleihau marwolaethau o hepatitis B ac C 65 y cant erbyn 2030. Mae grŵp goruchwylio'r rhaglen ddileu hepatitis B ac C wedi'i sefydlu i lywio'r agenda ddileu yma yng Nghymru. Mae'r grŵp yn cynnwys cynrychiolaeth o Lywodraeth Cymru, Iechyd Cyhoeddus Cymru, gwasanaethau iechyd hepatitis B ac C a'r trydydd sector. Cam gweithredu cyntaf y grŵp oedd cytuno ar gynnwys deunydd cyfathrebu a fydd yn nodi cynllun i ailfywiogi'r ymgyrch i ddileu hepatitis B ac C fel bygythiad i iechyd y cyhoedd erbyn 2030. Disgwylir iddo gael ei gyhoeddi'n fuan. O ran ein hymagwedd ehangach at glefyd yr afu, mae Llywodraeth Cymru, byrddau iechyd a strwythurau rhwydwaith newydd gweithrediaeth y GIG yn gweithio'n agos gyda'i gilydd i hybu'r gwaith o weithredu'r datganiad ansawdd ar gyfer clefyd yr afu. Mae'r datganiad ansawdd yn nodi ein gweledigaeth ar gyfer gwasanaethau clefyd yr afu o ansawdd uchel dros y degawd nesaf. Ei nod yw sicrhau gwell canlyniadau atal, canfod a thrin clefyd yr afu yma yng Nghymru. Mae'n cynnwys cefnogi amrywiaeth o fentrau, y cynigir rhai ohonynt ym mhwynt 4 y cynnig heddiw: cynlluniau megis parhau i dynnu sylw at fanteision sylweddol cyflwyno sgriniadau alcohol mewn adrannau achosion brys a thimau gofal alcohol saith diwrnod mewn gofal eilaidd i ddiwallu anghenion lleol; ehangu'r defnydd o lwybr profion gwaed yr afu Cymru mewn gofal sylfaenol, wedi'i ategu gan y Sefydliad Gwyddoniaeth Glinigol a Thechnoleg; ariannu staff i leihau amseroedd aros ar gyfer canfod clefyd cronig yr afu mewn modd anfewnwthiol; ariannu ymgyrchoedd Carwch Eich Afu gan Ymddiriedolaeth Afu Prydain; gwella'r ddarpariaeth ar gyfer hyfforddeion gastroenteroleg yng Nghymru i ymgymryd â hyfforddiant hepatoleg uwch gan arwain at gyflenwad gwell o hepatolegwyr ymgynghorol. Mae grŵp gweithredu ar gyfer clefyd yr afu wrthi'n datblygu rhaglen waith i gefnogi'r gwaith o weithredu'r datganiad ansawdd, a bydd amserlenni a blaenoriaethau'n cael eu hystyried fel rhan o'r broses hon. O ran yr alwad i ddyblu staff hepatoleg yng Nghymru, byrddau iechyd ac ymddiriedolaethau'r GIG sy'n gyfrifol am recriwtio a chynllunio'r gweithlu, gyda chefnogaeth Addysg a Gwella Iechyd Cymru a sefydliadau partner eraill. Mae angen inni ddatblygu dull ar gyfer y gweithlu hepatoleg sy'n sicrhau'r cydbwysedd iawn rhwng y galw a'r cyflenwad, ac rydym yn benderfynol o fynd i'r afael â phroblemau sylfaenol recriwtio, cadw staff a chynllunio'r gweithlu'n effeithiol er mwyn sicrhau y gallwn ddarparu'r nifer cywir o staff gofal iechyd i ddiwallu anghenion gofal ein cleifion. Mae strategaeth y gweithlu, a gyhoeddwyd gan Addysg a Gwella Iechyd Cymru a Gofal Cymdeithasol Cymru, yn nodi ein gweledigaeth a chamau gweithredu hirdymor ar gyfer y gweithlu iechyd a gofal cymdeithasol. Rydym hefyd wedi datblygu cynllun gweithlu mwy byrdymor i helpu gyda'r pwysau presennol ar ein gweithlu, ac mae'r Gweinidog Iechyd a Gwasanaethau Cymdeithasol yn disgwyl ei gyhoeddi yn yr wythnosau nesaf. I gloi, hoffwn roi sicrwydd i'r Siambr fod lleihau marwolaethau clefyd yr afu drwy atal a diagnosis cynnar yn parhau i fod yn flaenoriaeth i'r Llywodraeth, a gofynnaf i'r Siambr gefnogi gwelliant y Llywodraeth heddiw. Diolch.